Columns | Column: Column Watch

Capillary liquid chromatography (CapLC) offers compelling advantages in sensitivity, solvent reduction, and compatibility with modern mass spectrometry, yet remains underutilized in routine analytical workflows. This article synthesizes expert discussions from a Pittcon 2026 networking session to examine why CapLC adoption has lagged despite decades of development. Key themes include educational gaps, instrumentation limitations, robustness concerns, detection challenges, and supply‑chain constraints. The discussion highlights areas where CapLC already delivers clear value—such as proteomics, oligonucleotide analysis, and high‑throughput screening—and outlines practical pathways for broader adoption through targeted applications, improved instrumentation, and redefined expectations of “routine” chromatography.

Part 1 of this two-part article series reviews the history of slalom chromatography (SC), the rationale for its recent revival, and the updated mechanistic framework of this technique. Rooted in the fundamental physical properties of deoxyribonucleic acid/ribonucleic acid (DNA/RNA) biopolymers and laminar flow dynamics in packed chromatographic beds, SC is highlighted for its most promising applications in cell and gene therapy. Recent two-year experimental investigations have revealed that SC operates through an out‑of‑equilibrium mechanism, coupling the entropic elasticity of double‑stranded deoxyribonucleic acid/ribonucleic acid (dsDNA/RNA) with the extension and shear forces generated within the interparticle spaces of ultrahigh-pressure liquid chromatography (UHPLC) columns. In contrast to gel permeation chromatography (GPC) or hydrodynamic chromatography (HDC), SC functions at high speed and uniquely elutes smaller dsDNA fragments first, followed by progressively larger ones. Unlike agarose gel electrophoresis (AGE), SC achieves separations of large DNAs in less than three minutes, with nearly twice the resolution power of typical AGE. These findings paved the way for the recent design of a new SC column intended for use in cell and gene therapy as an alternative to standard AGE. Further applications of this new SC column within cell and gene therapy workflows will be discussed in Part 2.

The aim of this article is to provide a validated and optimized CIC-based method for accurate measurement of total fluorine in materials with polymeric PFAS content in the low-ppm range, which could be used in the consumer electronics and potentially other industries. This, in turn, can aid companies in tracking and mitigating PFAS ahead of regulations.